{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:33:44Z","timestamp":1789385624985,"version":"build-2803163510"},"reference-count":48,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Research Foundation of Korea (NRF)","award":["NRF-2023R1A2C1006384"],"award-info":[{"award-number":["NRF-2023R1A2C1006384"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Cisplatin, a platinum-based chemotherapeutic, is effective against various solid tumors, but its use is often limited by its nephrotoxic effects. This study evaluated the protective effects of trametinib, an FDA-approved selective inhibitor of mitogen-activated protein kinase kinase 1\/2 (MEK1\/2), against cisplatin-induced acute kidney injury (AKI) in mice. The experimental design included four groups, control, trametinib, cisplatin, and a combination of cisplatin and trametinib, each consisting of eight mice. Cisplatin was administered intraperitoneally at a dose of 20 mg\/kg to induce kidney injury, while trametinib was administered via oral gavage at 3 mg\/kg daily for three days. Assessments were conducted 72 h after cisplatin administration. Our results demonstrate that trametinib significantly reduces the phosphorylation of MEK1\/2 and extracellular signal-regulated kinase 1\/2 (ERK1\/2), mitigated renal dysfunction, and ameliorated histopathological abnormalities. Additionally, trametinib significantly decreased macrophage infiltration and the expression of pro-inflammatory cytokines in the kidneys. It also lowered lipid peroxidation by-products, restored the reduced glutathione\/oxidized glutathione ratio, and downregulated NADPH oxidase 4. Furthermore, trametinib significantly inhibited both apoptosis and necroptosis in the kidneys. In conclusion, our data underscore the potential of trametinib as a therapeutic agent for cisplatin-induced AKI, highlighting its role in reducing inflammation, oxidative stress, and tubular cell death.<\/jats:p>","DOI":"10.3390\/molecules29122881","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T11:14:16Z","timestamp":1718622856000},"page":"2881","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of Trametinib in Alleviating Cisplatin-Induced Acute Kidney Injury: Inhibition of Inflammation, Oxidative Stress, and Tubular Cell Death in a Mouse Model"],"prefix":"10.3390","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0001-8951","authenticated-orcid":false,"given":"Joung Eun","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, School of Medicine, Daegu Catholic University, Daegu 42472, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7229-1466","authenticated-orcid":false,"given":"Jung-Yeon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Immunology, School of Medicine, Daegu Catholic University, Daegu 42472, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2329-4374","authenticated-orcid":false,"given":"Jaechan","family":"Leem","sequence":"additional","affiliation":[{"name":"Department of Immunology, School of Medicine, Daegu Catholic University, Daegu 42472, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: Molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"McSweeney, K.R., Gadanec, L.K., Qaradakhi, T., Ali, B.A., Zulli, A., and Apostolopoulos, V. (2021). Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations. Cancers, 13.","DOI":"10.3390\/cancers13071572"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41581-022-00631-7","article-title":"Cisplatin nephrotoxicity: New insights and therapeutic implications","volume":"19","author":"Tang","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of Cisplatin Nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.fct.2018.07.018","article-title":"Role of food-derived antioxidants against cisplatin induced-nephrotoxicity","volume":"120","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/bs.acr.2021.03.008","article-title":"Cisplatin chemotherapy and renal function","volume":"152","author":"Zhang","year":"2021","journal-title":"Adv. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00204-014-1239-1","article-title":"Mitochondrial dysregulation and protection in cisplatin nephrotoxicity","volume":"88","author":"Yang","year":"2014","journal-title":"Arch. Toxicol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Alassaf, N., and Attia, H. (2023). Autophagy and necroptosis in cisplatin-induced acute kidney injury: Recent advances regarding their role and therapeutic potential. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1103062"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41419-023-06144-w","article-title":"Emerging significance and therapeutic targets of ferroptosis: A potential avenue for human kidney diseases","volume":"14","author":"Li","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41419-023-06005-6","article-title":"Pyroptosis in renal inflammation and fibrosis: Current knowledge and clinical significance","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1042\/BST20220271","article-title":"ERK1\/2 in immune signalling","volume":"50","author":"Lucas","year":"2022","journal-title":"Biochem. Soc. Trans."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Zhang, H.J., Liao, H.Y., Bai, D.Y., Wang, Z.Q., and Xie, X.W. (2021). MAPK\/ERK signaling pathway: A potential target for the treatment of intervertebral disc degeneration. Biomed. Pharmacother., 143.","DOI":"10.1016\/j.biopha.2021.112170"},{"key":"ref_13","first-page":"1997","article-title":"ERK\/MAPK signalling pathway and tumorigenesis","volume":"19","author":"Guo","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1523-1755.2005.67102.x","article-title":"MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis","volume":"67","author":"Jo","year":"2005","journal-title":"Kidney Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1124\/jpet.114.213769","article-title":"The water-soluble triptolide derivative PG490-88 protects against cisplatin-induced acute kidney injury","volume":"349","author":"Kim","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.bbadis.2013.05.023","article-title":"ERK-mediated suppression of cilia in cisplatin-induced tubular cell apoptosis and acute kidney injury","volume":"1832","author":"Wang","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.7150\/ijbs.24612","article-title":"Review of Drug Repositioning Approaches and Resources","volume":"14","author":"Xue","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1203421","article-title":"Improved survival with MEK inhibition in BRAF-mutated melanoma","volume":"367","author":"Flaherty","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2146\/ajhp140045","article-title":"Trametinib: A novel signal transduction inhibitor for the treatment of metastatic cutaneous melanoma","volume":"72","author":"Chung","year":"2015","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Brown, C.N., Atwood, D.J., Pokhrel, D., Ravichandran, K., Holditch, S.J., Saxena, S., Miyazaki, M., Nemenoff, R., Weiser-Evans, M.C.M., and Ljubanovic, D.G. (2020). The effect of MEK1\/2 inhibitors on cisplatin-induced acute kidney injury (AKI) and cancer growth in mice. Cell. Signal., 71.","DOI":"10.1016\/j.cellsig.2020.109605"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Jo, J., Kim, J.-Y., and Leem, J. (2022). Protective Effects of Orexin A in a Murine Model of Cisplatin-Induced Acute Kidney Injury. J. Clin. Med., 11.","DOI":"10.3390\/jcm11237196"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Marable, S.S., Chung, E., Adam, M., Potter, S.S., and Park, J.S. (2018). Hnf4a deletion in the mouse kidney phenocopies Fanconi renotubular syndrome. JCI Insight, 3.","DOI":"10.1172\/jci.insight.97497"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/CAD.0000000000001106","article-title":"BRAF\/MEK inhibitor-associated nephrotoxicity in a real-world setting and human kidney cells","volume":"32","author":"Sanagawa","year":"2021","journal-title":"Anticancer Drugs"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.kint.2019.05.006","article-title":"Inhibition of the ERK1\/2-mTORC1 axis ameliorates proteinuria and the fibrogenic action of transforming growth factor-\u03b2 in Adriamycin-induced glomerulosclerosis","volume":"96","author":"Das","year":"2019","journal-title":"Kidney Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1681\/ASN.2018020209","article-title":"The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1\/2 and mTORC1 Signaling","volume":"30","author":"Andrikopoulos","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Kim, J.-Y., Jo, J., Kim, K., An, H.-J., Gwon, M.-G., Gu, H., Kim, H.-J., Yang, A.Y., Kim, S.-W., and Jeon, E.J. (2019). Pharmacological Activation of Sirt1 Ameliorates Cisplatin-Induced Acute Kidney Injury by Suppressing Apoptosis, Oxidative Stress, and Inflammation in Mice. Antioxidants, 8.","DOI":"10.3390\/antiox8080322"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/ki.2012.226","article-title":"Signaling through the interleukin-18 receptor \u03b1 attenuates inflammation in cisplatin-induced acute kidney injury","volume":"82","author":"Nozaki","year":"2012","journal-title":"Kidney Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/sj.ki.5002242","article-title":"Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells","volume":"72","author":"Zhang","year":"2007","journal-title":"Kidney Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1172\/JCI200215606","article-title":"TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity","volume":"110","author":"Ramesh","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3109\/10715762.2015.1038258","article-title":"Arctigenin suppresses transforming growth factor-\u03b21-induced expression of monocyte chemoattractant protein-1 and the subsequent epithelial-mesenchymal transition through reactive oxygen species-dependent ERK\/NF-\u03baB signaling pathway in renal tubular epithelial cells","volume":"49","author":"Li","year":"2015","journal-title":"Free Radic. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7660","DOI":"10.1111\/jcmm.16603","article-title":"METTL3\/N6-methyladenosine\/miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1\/ERK\/NF-\u03baB pathway activation","volume":"25","author":"Liu","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Zhang, Q., Liu, L., Hu, Y., Shen, L., Li, L., and Wang, Y. (2022). Kv1.3 channel is involved in ox-LDL-induced macrophage inflammation via ERK\/NF-kappaB signaling pathway. Arch. Biochem. Biophys., 730.","DOI":"10.1016\/j.abb.2022.109394"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12964-023-01394-9","article-title":"Targeting Src homology phosphatase 2 ameliorates mouse diabetic nephropathy by attenuating ERK\/NF-\u03baB pathway-mediated renal inflammation","volume":"21","author":"Yu","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.freeradbiomed.2018.06.042","article-title":"Nox4 in renal diseases: An update","volume":"124","author":"Yang","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/labinvest.2017.120","article-title":"NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation","volume":"98","author":"Meng","year":"2018","journal-title":"Lab. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Gao, Y., Lu, X., Zhang, G., Liu, C., Sun, S., Mao, W., Jiang, G., Zhou, Y., Zhang, N., and Tao, S. (2024). DRD4 alleviates acute kidney injury by suppressing ISG15\/NOX4 axis-associated oxidative stress. Redox Biol., 70.","DOI":"10.1016\/j.redox.2024.103078"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Xia, Z., Wei, Z., Li, X., Liu, Y., Gu, X., Huang, S., Zhang, X., and Wang, W. (2024). C\/EBP\u03b1 aggravates renal fibrosis in CKD through the NOX4-ROS-apoptosis pathway in tubular epithelial cells. Biochim. Biophys. Acta Mol. Basis Dis., 1870.","DOI":"10.1016\/j.bbadis.2024.167039"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Lee, S.R., Lee, H.E., Yoo, J.Y., An, E.J., Song, S.J., Han, K.H., Cha, D.R., and Bae, Y.S. (2024). Nox4-SH3YL1 complex is involved in diabetic nephropathy. iScience, 27.","DOI":"10.1016\/j.isci.2024.108868"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1161\/CIRCRESAHA.109.215392","article-title":"Nox4 is a novel inducible source of reactive oxygen species in monocytes and macrophages and mediates oxidized low density lipoprotein-induced macrophage death","volume":"106","author":"Lee","year":"2010","journal-title":"Circ. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.bbrc.2020.06.034","article-title":"Activation of ERK1\/2-mTORC1-NOX4 mediates TGF-\u03b21-induced epithelial-mesenchymal transition and fibrosis in retinal pigment epithelial cells","volume":"529","author":"Kim","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"18606","DOI":"10.18632\/aging.203305","article-title":"Obesity increases neuropathic pain via the AMPK-ERK-NOX4 pathway in rats","volume":"13","author":"Fu","year":"2021","journal-title":"Aging"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41420-024-01872-0","article-title":"The interplay of mitophagy, autophagy, and apoptosis in cisplatin-induced kidney injury: Involvement of ERK signaling pathway","volume":"10","author":"Suman","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1681\/ASN.2014080741","article-title":"A Role for Tubular Necroptosis in Cisplatin-Induced AKI","volume":"26","author":"Xu","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1042\/CS20190599","article-title":"RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress","volume":"133","author":"Wang","year":"2019","journal-title":"Clin. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3389\/fphar.2018.00384","article-title":"Necrostatin-1 Attenuates Cisplatin-Induced Nephrotoxicity Through Suppression of Apoptosis and Oxidative Stress and Retains Klotho Expression","volume":"9","author":"Ning","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000525491","article-title":"Modeling Cisplatin-Induced Kidney Injury to Increase Translational Potential","volume":"147","author":"Sears","year":"2023","journal-title":"Nephron"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Kim, J.-Y., Jo, J., Leem, J., and Park, K.-K. (2020). Inhibition of p300 by Garcinol Protects against Cisplatin-Induced Acute Kidney Injury through Suppression of Oxidative Stress, Inflammation, and Tubular Cell Death in Mice. Antioxidants, 9.","DOI":"10.3390\/antiox9121271"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Chen, H.C., Hou, H.Y., Sung, J.M., and Shieh, C.C. (2023). Deletion of NADPH oxidase 2 attenuates cisplatin-induced acute kidney injury through reducing ROS-induced proximal tubular cell injury and inflammation. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1097671"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/12\/2881\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:00:09Z","timestamp":1760108409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/12\/2881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,17]]},"references-count":48,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["molecules29122881"],"URL":"https:\/\/doi.org\/10.3390\/molecules29122881","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,17]]}}}